Aker BioMarine — AGM Information 2021

Mar 12, 2021

Aker BioMarine ASA – Minutes from Annual General Meeting

Aker BioMarine ASA – Minutes from Annual General Meeting

Fornebu, 12 March 2021

The Annual General Meeting of Aker BioMarine ASA was held today at 14:00 CET. All items were resolved in accordance with the notice of the Annual General Meeting.

Please see attached a copy of the Minutes from the Annual General Meeting.

For further information, please contact Martin Stenshall, Investor Relations

Mobile: +47 47 33 83 31

Email: martin.stenshall@akerbiomarine.com

About Aker BioMarine

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Admitted to trading on Euronext Growth, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL® Aqua), and animal feed applications (QRILL® Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. Read more: www.akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act